Cargando…

Korean Medication Algorithm Project for Bipolar Disorder 2022, Fifth Revision: An Executive Summary

OBJECTIVE: We revised the Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP), first published in 2002 and revised in 2006, 2010, 2014, and 2018, to reflect recent progress in the treatment of bipolar disorder. METHODS: The questionnaires consisted of 56 items for adult patients and 7...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woo, Young Sup, Bahk, Won-Myong, Jeong, Jong-Hyun, Lee, Jung Goo, Kim, Won, Sohn, InKi, Park, Sung-Yong, Shim, Se-Hoon, Seo, Jeong Seok, Choo, IL Han, Yang, Chan-Mo, Jung, Myung Hun, Jon, Duk-In, Kim, Moon-Doo, Yoon, Bo-Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606436/ https://www.ncbi.nlm.nih.gov/pubmed/36263649 http://dx.doi.org/10.9758/cpn.2022.20.4.747

Ejemplares similares

Korean Medication Algorithm Project for Bipolar Disorder 2022: Comparisons with Other Treatment Guidelines
por: Jeong, Jong-Hyun, et al.
Publicado: (2023)

Korean Medication Algorithm Project for Bipolar Disorder: third revision
por: Woo, Young Sup, et al.
Publicado: (2015)

Korean Medication Algorithm for Bipolar Disorder 2018: Comparisons with Other Treatment Guidelines
por: Jeong, Jong-Hyun, et al.
Publicado: (2019)

Korean Medication Algorithm Project for Bipolar Disorder 2018 (KMAP-BP 2018): Fourth Revision
por: Woo, Young Sup, et al.
Publicado: (2018)

Korean Medication Algorithm for Bipolar Disorder 2014: comparisons with other treatment guidelines
por: Jeong, Jong-Hyun, et al.
Publicado: (2015)

Korean Medication Algorithm for Depressive Disorder 2021, Fourth Revision: An Executive Summary
por: Seo, Jeong Seok, et al.
Publicado: (2021)

Antidepressants and Mood Stabilizers: Novel Research Avenues and Clinical Insights for Bipolar Depression
por: Shim, In Hee, et al.
Publicado: (2017)

Prevalence of bipolar spectrum disorder in Korean college students according to the K-MDQ
por: Bae, Seung Oh, et al.
Publicado: (2013)

Psychometric Properties of the Korean Version of Functioning Assessment Short Test in Bipolar Disorder
por: Kang, Hangoeunbi, et al.
Publicado: (2023)

Neuromolecular Etiology of Bipolar Disorder: Possible Therapeutic Targets of Mood Stabilizers
por: Lee, Jung Goo, et al.
Publicado: (2022)

The Diagnostic Stability of DSM-IV Diagnoses: An Examination of Major Depressive Disorder, Bipolar I Disorder, and Schizophrenia in Korean Patients
por: Kim, Won, et al.
Publicado: (2011)

Blonanserin Augmentation of Atypical Antipsychotics in Patients with Schizophrenia-Who Benefits from Blonanserin Augmentation?: An Open-Label, Prospective, Multicenter Study
por: Woo, Young Sup, et al.
Publicado: (2016)

Clinical assessment of bipolar depression: validity, factor structure and psychometric properties of the Korean version of the Bipolar Depression Rating Scale (BDRS)
por: Jung, Young-Eun, et al.
Publicado: (2016)

The prevalence of bipolar spectrum disorder in elderly patients with recurrent depression
por: Lee, Chang-In, et al.
Publicado: (2014)

Vitamin D Deficiency/Insufficiency among Inpatients with Depressive Symptoms
por: Woo, Young Sup, et al.
Publicado: (2019)

Effect of Initial Ziprasidone Dose on Treatment Outcome of Korean Patients with Acute Manic or Mixed Episodes
por: Woo, Young Sup, et al.
Publicado: (2011)

Clinical correlates associated with the long-term response of bipolar disorder patients to lithium, valproate or lamotrigine: A retrospective study
por: Woo, Young Sup, et al.
Publicado: (2020)

Efficacy of quetiapine in patients with bipolar I and II depression: a multicenter, prospective, open-label, observational study
por: Jeong, Jong-Hyun, et al.
Publicado: (2013)

Korean Medication Algorithm for Depressive Disorders 2017: Third Revision
por: Seo, Jeong Seok, et al.
Publicado: (2018)

Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines
por: Wang, Hee Ryung, et al.
Publicado: (2017)

The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD): Changes in Preferred Treatment Strategies and Medications over 20 Years and Five Editions
por: Jang, Seung-Ho, et al.
Publicado: (2023)

Lurasidone as a potential therapy for bipolar disorder
por: Woo, Young Sup, et al.
Publicado: (2013)

Predictors of a Shorter Time to Hospitalization in Patients with Bipolar Disorder: Medication during the Acute and Maintenance Phases and Other Clinical Factors
por: Shim, In Hee, et al.
Publicado: (2017)

Screening with the Korean Version of the Mood Disorder Questionnaire for Bipolar Disorders in Adolescents: Korean Validity and Reliability Study
por: Shim, Se-Hoon, et al.
Publicado: (2018)

The Relationship between Cognitive Decline and Psychopathology in Patients with Schizophrenia and Bipolar Disorder
por: Kim, Moon-Doo, et al.
Publicado: (2015)

Dose Trends of Aripiprazole from 2004 to 2014 in Psychiatric Inpatients in Korea
por: Woo, Young Sup, et al.
Publicado: (2017)

Prevalence and Comorbidities of Adult Attention-deficit/ hyperactivity Disorder in a Community Sample from Korea
por: Woo, Young Sup, et al.
Publicado: (2023)

Improving the Screening Instrument of Bipolar Spectrum Disorders: Weighted Korean Version of the Mood Disorder Questionnaire
por: Hong, Narei, et al.
Publicado: (2018)

Pharmacological Treatment of Major Depressive Episodes with Mixed Features: A Systematic Review
por: Shim, In Hee, et al.
Publicado: (2018)

The Korean Medication Algorithm Project for Depressive Disorder 2021: Comparisons with Other Treatment Guidelines
por: Woo, Young Sup, et al.
Publicado: (2022)

Factors associated with antenatal depression in pregnant Korean females: the effect of bipolarity on depressive symptoms
por: Park, Chul Min, et al.
Publicado: (2014)

Sleep-Related Eating Disorder Associated With Mirtazapine
por: Jeong, Jong-Hyun, et al.
Publicado: (2014)

PM423. Blonanserin augmentation in patients with schizophrenia – who is benefited from blonanserin augmentation?: An open-label, prospective, multicenter study
por: Woo, Young Sup, et al.
Publicado: (2016)

Erratum: Lee, J.G., et al. The Neuroprotective Effects of Melatonin: Possible Role in the Pathophysiology of Neuropsychiatric Disease. Brain Sciences 2019, 9(10), 285
por: Lee, Jung Goo, et al.
Publicado: (2019)

The Neuroprotective Effects of Melatonin: Possible Role in the Pathophysiology of Neuropsychiatric Disease
por: Lee, Jung Goo, et al.
Publicado: (2019)

Efficacy and safety of generic escitalopram (Lexacure(®)) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram-comparative, non-inferiority study
por: Jeong, Jong-Hyun, et al.
Publicado: (2015)

Validation of the fifth edition BI-RADS ultrasound lexicon with comparison of fourth and fifth edition diagnostic performance using video clips
por: Yoon, Jung Hyun, et al.
Publicado: (2016)

Validation of the Korean Version of the Depression in Old Age Scale and Comparison with Other Depression Screening Questionnaires Used in Elderly Patients in Medical Settings
por: Jung, Young-Eun, et al.
Publicado: (2019)

The Influence of Current Mood States on Screening Accuracy of the Mood Disorder Questionnaire
por: Wang, Hee Ryung, et al.
Publicado: (2020)

Factors associated with bullying victimization among Korean adolescents
por: Seo, Hye-Jin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mqfo4kofrdj5i0b8n1ppan9aj3